首页> 外文期刊>European Journal of Medicinal Chemistry: Chimie Therapeutique >Synthesis of 1-naphtylpiperazine derivatives as serotoninergic ligands and their evaluation as antiproliferative agents.
【24h】

Synthesis of 1-naphtylpiperazine derivatives as serotoninergic ligands and their evaluation as antiproliferative agents.

机译:1-萘基哌嗪衍生物作为5-羟色胺能配体的合成及其作为抗增殖剂的评价。

获取原文
获取原文并翻译 | 示例
           

摘要

Serotonin (5-hydroxytryptamine, 5-HT) is one of the most important neuromediator involved in numerous physiological and pathophysiological processes. In addition it is well established that 5-HT acts as a growth factor on several types of non-tumoral and tumoral cells, and recently it was also related to oncogenes. 5-HT1A receptor expression was identified in prostatic tumor cell lines (PC3 cells) and in human hormone refractory prostate cancer tissue. Based on these observations, development of 5-HT1A antagonists could be useful in inhibiting the growth of cancer cells. In order to investigate on potential use of 5-HT1A ligands as antiproliferative agents, we have analyzed a new set of 1-naphtylpiperazine derivatives. In binding studies, several molecules showed affinity in nanomolar and subnanomolar range at 5-HT1A and moderate to no affinity for other relevant receptors (5-HT2A, 5-HT2C, D1, D2, alpha1 and alpha2). All compounds were then evaluated in order to assess their antiproliferative activity using PC3 cells and the most active compounds (1 and 2) were fully characterized to define the mechanism responsible for the observed antiproliferative effect.
机译:血清素(5-羟色胺,5-HT)是参与众多生理和病理生理过程的最重要的神经介质之一。此外,众所周知,5-HT在多种类型的非肿瘤和肿瘤细胞中起生长因子的作用,最近它也与癌基因有关。在前列腺肿瘤细胞系(PC3细胞)和人类激素难治性前列腺癌组织中鉴定出5-HT1A受体表达。基于这些观察,开发5-HT1A拮抗剂可用于抑制癌细胞的生长。为了研究5-HT1A配体作为抗增殖剂的潜在用途,我们分析了一组新的1-萘基哌嗪衍生物。在结合研究中,几种分子在5-HT1A处的纳摩尔和亚纳摩尔范围内显示出亲和力,而对其他相关受体(5-HT2A,5-HT2C,D1,D2,alpha1和alpha2)的亲和力中等至无亲和力。然后使用PC3细胞评估所有化合物,以评估其抗增殖活性,并对最具活性的化合物(1和2)进行充分表征,以确定引起所观察到的抗增殖作用的机制。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号